New Delhi, 24 March 2025: The Central Drugs Standard Control Organisation (CDSCO) has asked all small and medium-sized pharmaceutical manufacturers to submit only online applications to seek extension for adhering to revised Schedule M norms.
 
In a View Details

Related News

• A drug manufacturing facility operating without license busted in Kharkhoda (25-03-2025)

---

• Delhi HC allows Natco to make Roche's spinal muscular atrophy drug 'Risdiplam' in public interest (25-03-2025)

---

• Enforce regulations, strengthen penalties to fight the menace of counterfeit drugs: Parliamentary Panel (25-03-2025)

---

• Supplement firm Bioventra warns of online fakes (25-03-2025)

---

• FDA drug approvals drops, but smaller pharma leads innovation: GlobalData (25-03-2025)

---

• No staff involved in promoting fake drugs, vaccination: Odisha Health Minister (25-03-2025)

---

• Centre to introduce standardised hospital billing format to ensure transparency (24-03-2025)

---

• Father and son arrested for unlicensed medicine sales, concealed drugs in cowshed (24-03-2025)

---

• AI-driven device by PGI set to transform neuropathic pain diagnosis (24-03-2025)

---

• Chhattisgarh EOW Arrests Five Officers in ₹660 Cr Procurement Scam (24-03-2025)

---